"Positive data on cognition 'baked in',  Not sure about that, We have no clue about the details of any of the cognitive data yet just some positive  subtle hints based on the titles of the presentations.   What I am wondering is how will the market react if the data is really good,   How much appreciation will we have,  Being listed on the TSx will that limit the appreciation based on those in US retail investors not able to purchase shares other than the pinks.  I could only imagine Biogen market cap valuation appreciation if they were the ones presenting our postive cognitive data instead of RVX independantly.   There seems to be a real disconnect in valuation of this little small cap biotech with huge potential!!  We' see what happens Thursday and Friday